 Charles Snyder
Concepts (605)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Appendicitis | 19 | 2022 | 118 | 4.630 |
Why?
| | Appendectomy | 15 | 2022 | 103 | 2.880 |
Why?
| | Humans | 147 | 2023 | 6599 | 2.820 |
Why?
| | Male | 94 | 2023 | 3197 | 2.340 |
Why?
| | Retrospective Studies | 72 | 2023 | 1251 | 2.260 |
Why?
| | Female | 85 | 2023 | 3436 | 2.050 |
Why?
| | Child | 78 | 2023 | 3146 | 2.020 |
Why?
| | Laparoscopy | 23 | 2022 | 215 | 2.010 |
Why?
| | Pediatrics | 7 | 2016 | 170 | 1.880 |
Why?
| | Funnel Chest | 14 | 2022 | 55 | 1.660 |
Why?
| | Infant, Newborn | 41 | 2021 | 790 | 1.540 |
Why?
| | Treatment Outcome | 36 | 2023 | 624 | 1.430 |
Why?
| | Adolescent | 50 | 2023 | 2087 | 1.410 |
Why?
| | Postoperative Complications | 20 | 2023 | 177 | 1.320 |
Why?
| | Intestinal Obstruction | 5 | 2012 | 19 | 1.290 |
Why?
| | Infant | 40 | 2023 | 1396 | 1.220 |
Why?
| | Child, Preschool | 41 | 2020 | 1459 | 1.210 |
Why?
| | Tracheoesophageal Fistula | 10 | 2006 | 26 | 1.180 |
Why?
| | Hernia, Inguinal | 5 | 2021 | 31 | 1.160 |
Why?
| | Esophageal Atresia | 11 | 2008 | 32 | 1.110 |
Why?
| | Enterocolitis, Necrotizing | 5 | 2013 | 67 | 1.080 |
Why?
| | Gastroesophageal Reflux | 6 | 2016 | 41 | 1.020 |
Why?
| | Catheterization | 6 | 2016 | 27 | 0.960 |
Why?
| | Abnormalities, Multiple | 6 | 2009 | 36 | 0.850 |
Why?
| | Intestinal Atresia | 4 | 2023 | 18 | 0.840 |
Why?
| | Cryptorchidism | 3 | 2016 | 8 | 0.840 |
Why?
| | General Surgery | 4 | 2013 | 18 | 0.820 |
Why?
| | Pyloric Stenosis | 4 | 2016 | 12 | 0.820 |
Why?
| | Duodenal Obstruction | 5 | 2023 | 15 | 0.810 |
Why?
| | Meckel Diverticulum | 2 | 2014 | 7 | 0.800 |
Why?
| | Hirschsprung Disease | 4 | 2021 | 53 | 0.780 |
Why?
| | Gallbladder Diseases | 3 | 2016 | 13 | 0.770 |
Why?
| | Digestive System Surgical Procedures | 4 | 2011 | 38 | 0.750 |
Why?
| | Incidence | 10 | 2014 | 125 | 0.730 |
Why?
| | Length of Stay | 19 | 2023 | 227 | 0.730 |
Why?
| | Anti-Bacterial Agents | 10 | 2022 | 238 | 0.720 |
Why?
| | Tourniquets | 1 | 2019 | 1 | 0.710 |
Why?
| | Emergencies | 1 | 2019 | 11 | 0.700 |
Why?
| | Extracorporeal Membrane Oxygenation | 4 | 2016 | 17 | 0.680 |
Why?
| | Congenital Abnormalities | 3 | 2016 | 11 | 0.650 |
Why?
| | Minimally Invasive Surgical Procedures | 8 | 2022 | 38 | 0.650 |
Why?
| | Laparotomy | 4 | 2012 | 21 | 0.640 |
Why?
| | Opioid-Related Disorders | 1 | 2017 | 15 | 0.630 |
Why?
| | Analgesics, Opioid | 1 | 2017 | 44 | 0.610 |
Why?
| | Esophagus | 6 | 2013 | 28 | 0.610 |
Why?
| | Follow-Up Studies | 20 | 2020 | 315 | 0.590 |
Why?
| | Internship and Residency | 3 | 2013 | 31 | 0.590 |
Why?
| | Diagnostic Imaging | 1 | 2016 | 14 | 0.590 |
Why?
| | Gastrostomy | 6 | 2022 | 62 | 0.570 |
Why?
| | Bone Morphogenetic Proteins | 2 | 2006 | 7 | 0.570 |
Why?
| | Wounds, Nonpenetrating | 5 | 2023 | 60 | 0.540 |
Why?
| | Duodenum | 2 | 2020 | 18 | 0.510 |
Why?
| | Hernia, Umbilical | 2 | 2021 | 15 | 0.500 |
Why?
| | Severity of Illness Index | 3 | 2011 | 142 | 0.500 |
Why?
| | Acute Disease | 3 | 2022 | 71 | 0.500 |
Why?
| | Soft Tissue Neoplasms | 2 | 2011 | 6 | 0.500 |
Why?
| | Neutropenia | 2 | 2011 | 13 | 0.500 |
Why?
| | Hospitals, Pediatric | 6 | 2017 | 178 | 0.490 |
Why?
| | Adult | 15 | 2019 | 1233 | 0.490 |
Why?
| | Fundoplication | 5 | 2010 | 36 | 0.480 |
Why?
| | Intestinal Perforation | 1 | 2013 | 11 | 0.470 |
Why?
| | Ileal Diseases | 1 | 2013 | 7 | 0.470 |
Why?
| | United States | 7 | 2020 | 646 | 0.470 |
Why?
| | Fraud | 1 | 2013 | 2 | 0.470 |
Why?
| | Publishing | 1 | 2013 | 6 | 0.470 |
Why?
| | Algorithms | 2 | 2011 | 103 | 0.460 |
Why?
| | Authorship | 1 | 2013 | 3 | 0.460 |
Why?
| | Surgical Wound Infection | 5 | 2021 | 43 | 0.460 |
Why?
| | Risk Factors | 10 | 2016 | 460 | 0.460 |
Why?
| | Fellowships and Scholarships | 1 | 2013 | 16 | 0.460 |
Why?
| | Pneumothorax | 4 | 2023 | 33 | 0.460 |
Why?
| | Spleen | 4 | 2023 | 29 | 0.460 |
Why?
| | Digestive System Abnormalities | 2 | 2012 | 7 | 0.450 |
Why?
| | Gastroschisis | 2 | 2005 | 21 | 0.450 |
Why?
| | Tomography, X-Ray Computed | 7 | 2011 | 116 | 0.440 |
Why?
| | Signal Transduction | 6 | 2006 | 107 | 0.440 |
Why?
| | Heart Defects, Congenital | 4 | 2008 | 81 | 0.440 |
Why?
| | Foreign Bodies | 3 | 2013 | 22 | 0.430 |
Why?
| | Pyloric Stenosis, Hypertrophic | 2 | 2023 | 23 | 0.430 |
Why?
| | Prospective Studies | 17 | 2020 | 508 | 0.420 |
Why?
| | Cholecystectomy, Laparoscopic | 4 | 2021 | 27 | 0.420 |
Why?
| | Rectum | 2 | 2010 | 25 | 0.420 |
Why?
| | Mediastinal Neoplasms | 1 | 2011 | 5 | 0.410 |
Why?
| | Airway Obstruction | 1 | 2011 | 13 | 0.410 |
Why?
| | Orthopedic Procedures | 3 | 2017 | 16 | 0.410 |
Why?
| | Personnel Selection | 1 | 2011 | 3 | 0.410 |
Why?
| | Surgical Mesh | 2 | 2010 | 8 | 0.400 |
Why?
| | Databases, Factual | 5 | 2016 | 105 | 0.400 |
Why?
| | Fibrosarcoma | 1 | 2011 | 2 | 0.400 |
Why?
| | Specialties, Surgical | 1 | 2011 | 13 | 0.400 |
Why?
| | Penis | 2 | 2009 | 3 | 0.400 |
Why?
| | Colitis | 1 | 2011 | 12 | 0.390 |
Why?
| | Cryosurgery | 2 | 2022 | 13 | 0.390 |
Why?
| | Esophagoscopy | 3 | 2010 | 11 | 0.390 |
Why?
| | Thoracotomy | 5 | 2023 | 17 | 0.390 |
Why?
| | Periodicity | 1 | 2010 | 3 | 0.380 |
Why?
| | Rectal Prolapse | 1 | 2010 | 9 | 0.380 |
Why?
| | Antineoplastic Agents | 1 | 2011 | 57 | 0.380 |
Why?
| | Enterocolitis | 2 | 2021 | 34 | 0.380 |
Why?
| | Abdominal Neoplasms | 1 | 2010 | 5 | 0.380 |
Why?
| | Gynecomastia | 1 | 2010 | 2 | 0.370 |
Why?
| | Mastectomy, Subcutaneous | 1 | 2010 | 3 | 0.370 |
Why?
| | Mammaplasty | 1 | 2010 | 4 | 0.370 |
Why?
| | Abdomen | 2 | 2022 | 13 | 0.360 |
Why?
| | Urachus | 2 | 2007 | 3 | 0.350 |
Why?
| | Pain, Postoperative | 4 | 2022 | 39 | 0.350 |
Why?
| | Braces | 2 | 2019 | 10 | 0.330 |
Why?
| | Pectus Carinatum | 2 | 2019 | 10 | 0.330 |
Why?
| | Risk Assessment | 3 | 2022 | 130 | 0.330 |
Why?
| | Hernia, Diaphragmatic | 2 | 2010 | 14 | 0.330 |
Why?
| | Meconium | 1 | 2008 | 3 | 0.330 |
Why?
| | Abdominal Injuries | 3 | 2023 | 27 | 0.330 |
Why?
| | Hernias, Diaphragmatic, Congenital | 2 | 2010 | 20 | 0.330 |
Why?
| | Umbilicus | 2 | 2011 | 9 | 0.330 |
Why?
| | Delivery, Obstetric | 2 | 2005 | 3 | 0.320 |
Why?
| | Down Syndrome | 1 | 2008 | 39 | 0.310 |
Why?
| | Prognosis | 8 | 2013 | 209 | 0.310 |
Why?
| | Infant, Newborn, Diseases | 1 | 2008 | 32 | 0.310 |
Why?
| | Patient Readmission | 3 | 2017 | 66 | 0.310 |
Why?
| | Hypospadias | 2 | 2005 | 3 | 0.310 |
Why?
| | Vitelline Duct | 1 | 2007 | 1 | 0.300 |
Why?
| | Mullerian Ducts | 1 | 2006 | 3 | 0.300 |
Why?
| | Uterus | 1 | 2006 | 8 | 0.290 |
Why?
| | Surgical Procedures, Operative | 2 | 2006 | 12 | 0.290 |
Why?
| | Abdominal Abscess | 3 | 2012 | 26 | 0.290 |
Why?
| | Recurrence | 9 | 2023 | 115 | 0.290 |
Why?
| | Analgesia, Epidural | 2 | 2019 | 10 | 0.290 |
Why?
| | Analgesia, Patient-Controlled | 2 | 2019 | 18 | 0.280 |
Why?
| | Relative Value Scales | 1 | 2006 | 2 | 0.280 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2006 | 4 | 0.280 |
Why?
| | Bone Morphogenetic Protein Receptors, Type II | 1 | 2005 | 1 | 0.280 |
Why?
| | Bone Morphogenetic Protein Receptors, Type I | 1 | 2005 | 2 | 0.280 |
Why?
| | Urinary Bladder | 1 | 2005 | 5 | 0.280 |
Why?
| | Urethra | 1 | 2005 | 5 | 0.280 |
Why?
| | Orchiopexy | 2 | 2015 | 6 | 0.270 |
Why?
| | Testis | 2 | 2015 | 7 | 0.270 |
Why?
| | Emergency Service, Hospital | 2 | 2017 | 129 | 0.260 |
Why?
| | Gestational Age | 3 | 2013 | 61 | 0.260 |
Why?
| | Catheterization, Central Venous | 4 | 1995 | 18 | 0.260 |
Why?
| | Case-Control Studies | 5 | 2011 | 202 | 0.260 |
Why?
| | Liver | 3 | 2023 | 119 | 0.260 |
Why?
| | Chest Tubes | 3 | 2023 | 24 | 0.250 |
Why?
| | Diagnostic Tests, Routine | 2 | 2020 | 17 | 0.250 |
Why?
| | Enteral Nutrition | 4 | 2023 | 62 | 0.250 |
Why?
| | Ceftriaxone | 3 | 2010 | 13 | 0.250 |
Why?
| | Metronidazole | 3 | 2010 | 14 | 0.250 |
Why?
| | Lung Neoplasms | 4 | 2008 | 22 | 0.240 |
Why?
| | Cost-Benefit Analysis | 4 | 2020 | 36 | 0.240 |
Why?
| | Appendix | 2 | 2016 | 11 | 0.240 |
Why?
| | Tissue Adhesions | 2 | 2017 | 6 | 0.230 |
Why?
| | Pregnancy | 5 | 2008 | 203 | 0.230 |
Why?
| | Time Factors | 5 | 2016 | 241 | 0.230 |
Why?
| | Probability | 3 | 2020 | 17 | 0.230 |
Why?
| | Bed Rest | 2 | 2013 | 10 | 0.220 |
Why?
| | Drainage | 5 | 2010 | 34 | 0.220 |
Why?
| | Body Weights and Measures | 1 | 2022 | 2 | 0.220 |
Why?
| | Postoperative Care | 2 | 2013 | 28 | 0.220 |
Why?
| | Sex Factors | 2 | 2014 | 71 | 0.220 |
Why?
| | Age of Onset | 3 | 2013 | 27 | 0.210 |
Why?
| | Birth Weight | 4 | 2005 | 27 | 0.210 |
Why?
| | Intubation, Gastrointestinal | 4 | 2010 | 18 | 0.210 |
Why?
| | Masks | 1 | 2021 | 7 | 0.210 |
Why?
| | Device Removal | 3 | 2014 | 13 | 0.200 |
Why?
| | Osteosarcoma | 3 | 1993 | 19 | 0.200 |
Why?
| | Infant, Premature | 2 | 2003 | 81 | 0.200 |
Why?
| | Animals | 11 | 2006 | 563 | 0.190 |
Why?
| | Nerve Tissue Proteins | 2 | 2003 | 24 | 0.190 |
Why?
| | Superior Mesenteric Artery Syndrome | 1 | 2020 | 4 | 0.190 |
Why?
| | Immunohistochemistry | 4 | 2006 | 36 | 0.190 |
Why?
| | Ligaments | 1 | 2020 | 4 | 0.190 |
Why?
| | Birth Injuries | 1 | 2000 | 1 | 0.190 |
Why?
| | Splenic Rupture | 1 | 2000 | 2 | 0.190 |
Why?
| | Computer-Assisted Instruction | 1 | 2020 | 3 | 0.190 |
Why?
| | Surgeons | 1 | 2020 | 5 | 0.190 |
Why?
| | Inpatients | 1 | 2020 | 44 | 0.190 |
Why?
| | Thoracic Surgical Procedures | 3 | 2010 | 10 | 0.190 |
Why?
| | Internet | 1 | 2020 | 16 | 0.190 |
Why?
| | Age Factors | 3 | 2010 | 203 | 0.190 |
Why?
| | Bile Duct Diseases | 1 | 2000 | 1 | 0.190 |
Why?
| | Cysts | 1 | 2000 | 4 | 0.180 |
Why?
| | Patient Discharge | 1 | 2020 | 58 | 0.180 |
Why?
| | Bayes Theorem | 1 | 2020 | 30 | 0.180 |
Why?
| | Reoperation | 5 | 2022 | 57 | 0.180 |
Why?
| | Manipulation, Orthopedic | 1 | 2019 | 5 | 0.180 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2019 | 15 | 0.170 |
Why?
| | Esophageal Stenosis | 2 | 2010 | 5 | 0.170 |
Why?
| | Apgar Score | 3 | 2005 | 6 | 0.170 |
Why?
| | Combined Modality Therapy | 2 | 2016 | 51 | 0.160 |
Why?
| | Prostheses and Implants | 2 | 2011 | 8 | 0.160 |
Why?
| | Medical Staff, Hospital | 2 | 2008 | 4 | 0.160 |
Why?
| | Doxorubicin | 4 | 2006 | 17 | 0.160 |
Why?
| | Survival Rate | 7 | 2003 | 84 | 0.160 |
Why?
| | Cyanoacrylates | 1 | 2017 | 2 | 0.160 |
Why?
| | Tissue Adhesives | 1 | 2017 | 3 | 0.160 |
Why?
| | Circumcision, Male | 1 | 2017 | 3 | 0.160 |
Why?
| | Hospitals, Low-Volume | 1 | 2017 | 1 | 0.160 |
Why?
| | Hospitals, High-Volume | 1 | 2017 | 2 | 0.160 |
Why?
| | Rats | 6 | 2006 | 97 | 0.160 |
Why?
| | Middle Aged | 4 | 2013 | 648 | 0.150 |
Why?
| | Enterocolitis, Pseudomembranous | 1 | 1997 | 4 | 0.150 |
Why?
| | Infant, Very Low Birth Weight | 1 | 1997 | 10 | 0.150 |
Why?
| | Rats, Sprague-Dawley | 5 | 2006 | 46 | 0.150 |
Why?
| | Patient Satisfaction | 3 | 2019 | 41 | 0.150 |
Why?
| | Abscess | 2 | 2008 | 10 | 0.150 |
Why?
| | Pylorus | 3 | 2006 | 12 | 0.150 |
Why?
| | Surgicenters | 1 | 2016 | 2 | 0.140 |
Why?
| | Models, Organizational | 1 | 2016 | 8 | 0.140 |
Why?
| | Therapeutic Irrigation | 1 | 2016 | 8 | 0.140 |
Why?
| | Antibiotic Prophylaxis | 3 | 2021 | 28 | 0.140 |
Why?
| | Clinical Protocols | 2 | 2013 | 35 | 0.140 |
Why?
| | Cohort Studies | 4 | 2010 | 264 | 0.140 |
Why?
| | Preoperative Care | 4 | 2010 | 25 | 0.140 |
Why?
| | Presynaptic Terminals | 1 | 1995 | 1 | 0.140 |
Why?
| | Corpus Striatum | 1 | 1995 | 2 | 0.140 |
Why?
| | Cerebral Cortex | 1 | 1995 | 6 | 0.140 |
Why?
| | Peritoneal Lavage | 2 | 2012 | 6 | 0.140 |
Why?
| | Age Distribution | 2 | 2012 | 31 | 0.140 |
Why?
| | Thoracoscopy | 4 | 2011 | 27 | 0.130 |
Why?
| | Membrane Proteins | 1 | 1995 | 50 | 0.130 |
Why?
| | Gastric Emptying | 1 | 1995 | 9 | 0.130 |
Why?
| | Xiphoid Bone | 2 | 2016 | 5 | 0.130 |
Why?
| | Gastric Fistula | 1 | 2015 | 3 | 0.130 |
Why?
| | Cutaneous Fistula | 1 | 2015 | 3 | 0.130 |
Why?
| | Ranitidine | 1 | 2015 | 5 | 0.130 |
Why?
| | Histamine H2 Antagonists | 1 | 2015 | 7 | 0.130 |
Why?
| | Proton Pump Inhibitors | 1 | 2015 | 13 | 0.130 |
Why?
| | Abnormalities, Drug-Induced | 2 | 2006 | 9 | 0.130 |
Why?
| | Needs Assessment | 2 | 2020 | 21 | 0.130 |
Why?
| | Kidney | 2 | 2009 | 89 | 0.130 |
Why?
| | Blood Volume | 3 | 1991 | 4 | 0.120 |
Why?
| | Kansas | 1 | 2014 | 49 | 0.120 |
Why?
| | Reproducibility of Results | 2 | 2011 | 197 | 0.120 |
Why?
| | Receptors, Fibroblast Growth Factor | 2 | 2004 | 2 | 0.120 |
Why?
| | Prosthesis Implantation | 2 | 2010 | 5 | 0.120 |
Why?
| | Injury Severity Score | 4 | 2023 | 58 | 0.120 |
Why?
| | Esthetics | 2 | 2011 | 7 | 0.120 |
Why?
| | Multiple Birth Offspring | 1 | 2013 | 2 | 0.120 |
Why?
| | Biopsy | 2 | 2010 | 56 | 0.120 |
Why?
| | Competitive Behavior | 1 | 2013 | 2 | 0.120 |
Why?
| | Job Application | 1 | 2013 | 2 | 0.120 |
Why?
| | Trans-Activators | 2 | 2003 | 11 | 0.120 |
Why?
| | Operative Time | 3 | 2022 | 31 | 0.120 |
Why?
| | Longitudinal Studies | 2 | 2010 | 123 | 0.110 |
Why?
| | Confidence Intervals | 1 | 2012 | 12 | 0.110 |
Why?
| | Sex Distribution | 1 | 2012 | 17 | 0.110 |
Why?
| | Odds Ratio | 1 | 2012 | 53 | 0.110 |
Why?
| | Prevalence | 1 | 2013 | 145 | 0.110 |
Why?
| | Suction | 1 | 2012 | 8 | 0.110 |
Why?
| | Fluoroscopy | 3 | 2013 | 19 | 0.110 |
Why?
| | Fluid Therapy | 2 | 2023 | 19 | 0.110 |
Why?
| | Disease Models, Animal | 3 | 2006 | 55 | 0.110 |
Why?
| | Anus, Imperforate | 1 | 2012 | 3 | 0.110 |
Why?
| | Duodenoscopy | 2 | 2008 | 3 | 0.110 |
Why?
| | Thoracic Vertebrae | 1 | 2011 | 4 | 0.110 |
Why?
| | Sternum | 1 | 2011 | 6 | 0.110 |
Why?
| | Anthropometry | 1 | 2011 | 16 | 0.110 |
Why?
| | Insufflation | 1 | 2011 | 3 | 0.100 |
Why?
| | Trachea | 3 | 2007 | 7 | 0.100 |
Why?
| | Pneumoperitoneum, Artificial | 1 | 2011 | 5 | 0.100 |
Why?
| | Diagnosis, Differential | 2 | 2005 | 74 | 0.100 |
Why?
| | Mediastinum | 1 | 2011 | 5 | 0.100 |
Why?
| | Enterostomy | 1 | 1991 | 2 | 0.100 |
Why?
| | Bone Neoplasms | 1 | 1991 | 23 | 0.100 |
Why?
| | Ultraviolet Rays | 1 | 1991 | 5 | 0.100 |
Why?
| | Fluorescent Dyes | 1 | 1991 | 5 | 0.100 |
Why?
| | Thorax | 1 | 2011 | 4 | 0.100 |
Why?
| | Axilla | 1 | 2011 | 2 | 0.100 |
Why?
| | Buttocks | 1 | 2011 | 2 | 0.100 |
Why?
| | Lymphoma | 1 | 2011 | 9 | 0.100 |
Why?
| | Leukemia | 1 | 2011 | 17 | 0.100 |
Why?
| | Water-Electrolyte Imbalance | 1 | 1990 | 1 | 0.100 |
Why?
| | Blood Pressure Monitors | 1 | 1990 | 1 | 0.100 |
Why?
| | Diaphragm | 1 | 2010 | 7 | 0.100 |
Why?
| | Jejunal Diseases | 1 | 1990 | 3 | 0.100 |
Why?
| | Syndrome | 2 | 2008 | 33 | 0.100 |
Why?
| | Patient Admission | 1 | 2010 | 9 | 0.100 |
Why?
| | Bone Marrow Transplantation | 1 | 1990 | 17 | 0.100 |
Why?
| | Kidney Pelvis | 1 | 2010 | 2 | 0.100 |
Why?
| | Ureteral Obstruction | 1 | 2010 | 5 | 0.100 |
Why?
| | Decompression, Surgical | 1 | 2010 | 3 | 0.100 |
Why?
| | Diagnostic Techniques, Digestive System | 1 | 2010 | 5 | 0.100 |
Why?
| | Nutritional Support | 1 | 2010 | 5 | 0.100 |
Why?
| | Esophageal pH Monitoring | 1 | 2010 | 4 | 0.100 |
Why?
| | Esophageal Perforation | 1 | 2010 | 4 | 0.090 |
Why?
| | Predictive Value of Tests | 4 | 2011 | 99 | 0.090 |
Why?
| | Nephrectomy | 1 | 2010 | 15 | 0.090 |
Why?
| | Gastrointestinal Tract | 1 | 2010 | 7 | 0.090 |
Why?
| | Fecal Incontinence | 1 | 2010 | 19 | 0.090 |
Why?
| | Nipples | 1 | 2010 | 3 | 0.090 |
Why?
| | Pneumonia | 1 | 1990 | 30 | 0.090 |
Why?
| | Nuclear Proteins | 4 | 2003 | 45 | 0.090 |
Why?
| | Logistic Models | 3 | 2017 | 91 | 0.090 |
Why?
| | Magnetic Resonance Imaging | 1 | 2011 | 114 | 0.090 |
Why?
| | Ultrasonography | 3 | 2006 | 42 | 0.090 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2010 | 4 | 0.090 |
Why?
| | Leukemic Infiltration | 1 | 2009 | 3 | 0.090 |
Why?
| | Azygos Vein | 1 | 1989 | 1 | 0.090 |
Why?
| | Cystic Fibrosis | 1 | 1989 | 18 | 0.090 |
Why?
| | Sensitivity and Specificity | 4 | 2011 | 145 | 0.090 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2009 | 60 | 0.080 |
Why?
| | Pressure | 2 | 2019 | 11 | 0.080 |
Why?
| | DNA-Binding Proteins | 3 | 2003 | 35 | 0.080 |
Why?
| | Transcription Factors | 3 | 2003 | 46 | 0.080 |
Why?
| | Workload | 1 | 2008 | 9 | 0.080 |
Why?
| | Gentamicins | 1 | 2008 | 5 | 0.080 |
Why?
| | Pregnancy in Diabetics | 1 | 2008 | 2 | 0.080 |
Why?
| | Ileus | 1 | 2008 | 3 | 0.080 |
Why?
| | Electrolytes | 2 | 2021 | 13 | 0.080 |
Why?
| | Rural Health Services | 1 | 2008 | 2 | 0.080 |
Why?
| | Urban Health Services | 1 | 2008 | 3 | 0.080 |
Why?
| | Patient Care Team | 1 | 2008 | 19 | 0.080 |
Why?
| | Comorbidity | 1 | 2008 | 61 | 0.080 |
Why?
| | Societies, Medical | 1 | 2008 | 43 | 0.080 |
Why?
| | Anastomosis, Surgical | 2 | 2023 | 22 | 0.080 |
Why?
| | Hospital Charges | 1 | 2007 | 11 | 0.080 |
Why?
| | Herniorrhaphy | 2 | 2021 | 25 | 0.080 |
Why?
| | Cost of Illness | 1 | 2007 | 19 | 0.080 |
Why?
| | Vomiting | 3 | 2020 | 23 | 0.080 |
Why?
| | Intestine, Small | 1 | 2007 | 14 | 0.080 |
Why?
| | Antithrombin III | 1 | 2007 | 2 | 0.080 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2007 | 2 | 0.080 |
Why?
| | Spinal Diseases | 1 | 2007 | 2 | 0.080 |
Why?
| | Survival Analysis | 3 | 2008 | 46 | 0.080 |
Why?
| | Urinary Tract | 1 | 2007 | 6 | 0.080 |
Why?
| | Anticoagulants | 1 | 2007 | 17 | 0.080 |
Why?
| | Disorders of Sex Development | 1 | 2006 | 9 | 0.070 |
Why?
| | Teratogens | 1 | 2006 | 5 | 0.070 |
Why?
| | Fibroblast Growth Factors | 2 | 2004 | 27 | 0.070 |
Why?
| | Urination | 1 | 2005 | 2 | 0.070 |
Why?
| | Ligands | 1 | 2005 | 5 | 0.070 |
Why?
| | Regression Analysis | 1 | 2006 | 56 | 0.070 |
Why?
| | Cesarean Section | 1 | 2005 | 3 | 0.070 |
Why?
| | Constriction, Pathologic | 2 | 2023 | 17 | 0.070 |
Why?
| | Health Care Costs | 1 | 2005 | 29 | 0.070 |
Why?
| | Islets of Langerhans | 1 | 2005 | 3 | 0.070 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2005 | 2 | 0.070 |
Why?
| | Transforming Growth Factor beta | 1 | 2005 | 10 | 0.070 |
Why?
| | Drug Therapy, Combination | 3 | 2010 | 38 | 0.070 |
Why?
| | Urologic Surgical Procedures | 1 | 2005 | 1 | 0.070 |
Why?
| | Diverticulum | 1 | 2005 | 4 | 0.070 |
Why?
| | Treatment Failure | 1 | 2005 | 17 | 0.070 |
Why?
| | Urinary Bladder Diseases | 1 | 2005 | 3 | 0.070 |
Why?
| | Staphylococcal Infections | 1 | 2005 | 21 | 0.070 |
Why?
| | Texas | 2 | 2023 | 16 | 0.070 |
Why?
| | Thyroglossal Cyst | 1 | 2004 | 1 | 0.060 |
Why?
| | Administration, Oral | 3 | 2010 | 59 | 0.060 |
Why?
| | Bacterial Infections | 1 | 2004 | 27 | 0.060 |
Why?
| | Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2003 | 2 | 0.060 |
Why?
| | Radiography | 3 | 2010 | 38 | 0.060 |
Why?
| | Causality | 1 | 2003 | 10 | 0.060 |
Why?
| | Foreign-Body Reaction | 1 | 2003 | 3 | 0.060 |
Why?
| | DNA Mutational Analysis | 1 | 2003 | 36 | 0.060 |
Why?
| | Osteogenesis | 1 | 2003 | 6 | 0.060 |
Why?
| | Anastomotic Leak | 1 | 2023 | 9 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 2003 | 38 | 0.060 |
Why?
| | Thoracic Injuries | 2 | 1996 | 8 | 0.060 |
Why?
| | Fetal Proteins | 1 | 2003 | 1 | 0.060 |
Why?
| | Infant, Premature, Diseases | 1 | 2003 | 23 | 0.060 |
Why?
| | Arizona | 1 | 2023 | 9 | 0.060 |
Why?
| | Arkansas | 1 | 2023 | 9 | 0.060 |
Why?
| | Oklahoma | 1 | 2023 | 11 | 0.060 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2003 | 33 | 0.060 |
Why?
| | Thoracic Surgery, Video-Assisted | 1 | 2023 | 18 | 0.060 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2003 | 64 | 0.060 |
Why?
| | Trauma Centers | 1 | 2023 | 41 | 0.060 |
Why?
| | Rupture, Spontaneous | 3 | 2011 | 7 | 0.060 |
Why?
| | Blood Loss, Surgical | 3 | 2012 | 5 | 0.050 |
Why?
| | Pilot Projects | 2 | 2015 | 124 | 0.050 |
Why?
| | Ovarian Neoplasms | 1 | 2003 | 132 | 0.050 |
Why?
| | Intercostal Nerves | 1 | 2022 | 7 | 0.050 |
Why?
| | Carbon Dioxide | 1 | 2021 | 16 | 0.050 |
Why?
| | Hospitals | 1 | 2021 | 38 | 0.050 |
Why?
| | Anal Canal | 1 | 2021 | 23 | 0.050 |
Why?
| | Outpatients | 1 | 2021 | 28 | 0.050 |
Why?
| | Antibodies | 2 | 2005 | 15 | 0.050 |
Why?
| | Rotation | 1 | 2020 | 5 | 0.050 |
Why?
| | Hemoperitoneum | 1 | 2000 | 2 | 0.050 |
Why?
| | Nausea | 1 | 2020 | 15 | 0.050 |
Why?
| | Dilatation, Pathologic | 1 | 2000 | 6 | 0.050 |
Why?
| | Pleural Diseases | 2 | 2011 | 5 | 0.050 |
Why?
| | Pain | 1 | 2020 | 53 | 0.050 |
Why?
| | Morbidity | 1 | 1999 | 11 | 0.040 |
Why?
| | DNA Nucleotidylexotransferase | 1 | 1999 | 3 | 0.040 |
Why?
| | Morphogenesis | 3 | 2004 | 7 | 0.040 |
Why?
| | Young Adult | 2 | 2012 | 652 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2010 | 92 | 0.040 |
Why?
| | Lung | 3 | 2004 | 65 | 0.040 |
Why?
| | Patient Compliance | 1 | 2019 | 70 | 0.040 |
Why?
| | Respiratory Tract Diseases | 2 | 2014 | 8 | 0.040 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 290 | 0.040 |
Why?
| | Turner Syndrome | 1 | 1998 | 1 | 0.040 |
Why?
| | Vena Cava, Inferior | 1 | 1998 | 3 | 0.040 |
Why?
| | Ductus Arteriosus, Patent | 1 | 1998 | 4 | 0.040 |
Why?
| | Colectomy | 2 | 1996 | 13 | 0.040 |
Why?
| | Laser Therapy | 3 | 1996 | 4 | 0.040 |
Why?
| | Endoscopy | 1 | 1998 | 15 | 0.040 |
Why?
| | Quality Assurance, Health Care | 1 | 2017 | 6 | 0.040 |
Why?
| | Risk Adjustment | 1 | 2017 | 5 | 0.040 |
Why?
| | Sutures | 1 | 2017 | 11 | 0.040 |
Why?
| | Quality Indicators, Health Care | 1 | 2017 | 17 | 0.040 |
Why?
| | Linear Models | 1 | 2017 | 55 | 0.040 |
Why?
| | Infusions, Intravenous | 2 | 2008 | 26 | 0.040 |
Why?
| | Dogs | 3 | 1990 | 16 | 0.040 |
Why?
| | Tracheal Diseases | 1 | 1996 | 1 | 0.040 |
Why?
| | Aorta | 1 | 1996 | 8 | 0.040 |
Why?
| | Nervous System Diseases | 1 | 1996 | 13 | 0.040 |
Why?
| | Colitis, Ulcerative | 1 | 1996 | 9 | 0.030 |
Why?
| | Inguinal Canal | 1 | 2015 | 3 | 0.030 |
Why?
| | Atrophy | 1 | 2015 | 6 | 0.030 |
Why?
| | Constriction | 1 | 1995 | 1 | 0.030 |
Why?
| | Needles | 1 | 1995 | 3 | 0.030 |
Why?
| | Intestinal Mucosa | 1 | 1996 | 34 | 0.030 |
Why?
| | Adenomatous Polyposis Coli | 1 | 1996 | 24 | 0.030 |
Why?
| | Syntaxin 1 | 1 | 1995 | 1 | 0.030 |
Why?
| | Microscopy, Electron | 1 | 1995 | 3 | 0.030 |
Why?
| | Qa-SNARE Proteins | 1 | 1995 | 2 | 0.030 |
Why?
| | Remission, Spontaneous | 1 | 2015 | 2 | 0.030 |
Why?
| | Gastrointestinal Motility | 2 | 2010 | 5 | 0.030 |
Why?
| | Accidents, Traffic | 2 | 1996 | 14 | 0.030 |
Why?
| | Appendiceal Neoplasms | 1 | 2014 | 2 | 0.030 |
Why?
| | Carcinoid Tumor | 1 | 2014 | 2 | 0.030 |
Why?
| | Cecal Diseases | 1 | 2014 | 2 | 0.030 |
Why?
| | Intestinal Neoplasms | 1 | 2014 | 2 | 0.030 |
Why?
| | Enterobiasis | 1 | 2014 | 2 | 0.030 |
Why?
| | Granuloma | 1 | 2014 | 4 | 0.030 |
Why?
| | Incidental Findings | 1 | 2014 | 8 | 0.030 |
Why?
| | Thoracostomy | 1 | 2014 | 8 | 0.030 |
Why?
| | Hemodynamics | 2 | 1991 | 8 | 0.030 |
Why?
| | Radiography, Thoracic | 1 | 2014 | 12 | 0.030 |
Why?
| | Vena Cava, Superior | 1 | 1993 | 1 | 0.030 |
Why?
| | Meconium Aspiration Syndrome | 1 | 1993 | 4 | 0.030 |
Why?
| | Femoral Artery | 1 | 1973 | 1 | 0.030 |
Why?
| | Solutions | 1 | 2013 | 4 | 0.030 |
Why?
| | Cerebral Hemorrhage | 1 | 1993 | 1 | 0.030 |
Why?
| | Jugular Veins | 1 | 1993 | 3 | 0.030 |
Why?
| | Sarcoma | 1 | 1993 | 6 | 0.030 |
Why?
| | Postoperative Nausea and Vomiting | 1 | 2013 | 6 | 0.030 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 2 | 2 | 2004 | 2 | 0.030 |
Why?
| | Angiography | 1 | 1973 | 8 | 0.030 |
Why?
| | Eosinophilia | 1 | 2014 | 20 | 0.030 |
Why?
| | Infant Formula | 1 | 2013 | 15 | 0.030 |
Why?
| | Appointments and Schedules | 1 | 2013 | 13 | 0.030 |
Why?
| | Milk, Human | 1 | 2013 | 21 | 0.030 |
Why?
| | Thrombosis | 1 | 1973 | 15 | 0.030 |
Why?
| | Embryonic and Fetal Development | 2 | 2003 | 5 | 0.030 |
Why?
| | Kruppel-Like Transcription Factors | 2 | 2003 | 6 | 0.030 |
Why?
| | Remission Induction | 1 | 2013 | 25 | 0.030 |
Why?
| | Hedgehog Proteins | 2 | 2003 | 5 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2004 | 107 | 0.030 |
Why?
| | Epithelium | 2 | 2003 | 6 | 0.030 |
Why?
| | Polymerase Chain Reaction | 2 | 2004 | 82 | 0.030 |
Why?
| | Intention to Treat Analysis | 1 | 2012 | 8 | 0.030 |
Why?
| | Cellulitis | 2 | 2005 | 6 | 0.030 |
Why?
| | Chi-Square Distribution | 2 | 2007 | 34 | 0.030 |
Why?
| | Missouri | 2 | 2007 | 78 | 0.030 |
Why?
| | False Negative Reactions | 1 | 2011 | 10 | 0.030 |
Why?
| | Single-Blind Method | 1 | 2011 | 12 | 0.030 |
Why?
| | Palpation | 1 | 1991 | 1 | 0.030 |
Why?
| | Mice | 2 | 2005 | 290 | 0.030 |
Why?
| | Blister | 1 | 2011 | 2 | 0.030 |
Why?
| | Regional Blood Flow | 1 | 1991 | 3 | 0.030 |
Why?
| | Ischemia | 1 | 1991 | 7 | 0.030 |
Why?
| | Splenectomy | 1 | 2011 | 7 | 0.030 |
Why?
| | Death | 1 | 1991 | 1 | 0.030 |
Why?
| | Shock, Hemorrhagic | 1 | 1991 | 4 | 0.030 |
Why?
| | Resuscitation | 2 | 1991 | 6 | 0.030 |
Why?
| | Early Ambulation | 1 | 2011 | 3 | 0.020 |
Why?
| | Guidelines as Topic | 1 | 2011 | 11 | 0.020 |
Why?
| | Intestines | 1 | 1991 | 26 | 0.020 |
Why?
| | Pulmonary Wedge Pressure | 1 | 1990 | 3 | 0.020 |
Why?
| | Minnesota | 1 | 1990 | 5 | 0.020 |
Why?
| | Wound Infection | 1 | 1990 | 4 | 0.020 |
Why?
| | Evaluation Studies as Topic | 1 | 1990 | 7 | 0.020 |
Why?
| | Extracellular Space | 1 | 1990 | 4 | 0.020 |
Why?
| | Blood Pressure Determination | 1 | 1990 | 14 | 0.020 |
Why?
| | Bronchoscopy | 1 | 1990 | 7 | 0.020 |
Why?
| | Immune Tolerance | 1 | 1990 | 8 | 0.020 |
Why?
| | Opportunistic Infections | 1 | 1990 | 7 | 0.020 |
Why?
| | Cholestasis, Extrahepatic | 1 | 1990 | 1 | 0.020 |
Why?
| | Amoxicillin | 1 | 2010 | 4 | 0.020 |
Why?
| | Ascites | 1 | 1990 | 4 | 0.020 |
Why?
| | Prosthesis Design | 1 | 2010 | 9 | 0.020 |
Why?
| | Injections, Intravenous | 1 | 2010 | 13 | 0.020 |
Why?
| | Iatrogenic Disease | 1 | 2010 | 7 | 0.020 |
Why?
| | Diagnostic Errors | 1 | 2010 | 7 | 0.020 |
Why?
| | Attitude | 1 | 2010 | 12 | 0.020 |
Why?
| | Hydrocephalus | 1 | 1989 | 8 | 0.020 |
Why?
| | Hypertrophy | 1 | 2009 | 4 | 0.020 |
Why?
| | Fever | 1 | 2009 | 26 | 0.020 |
Why?
| | Clinical Competence | 1 | 2010 | 32 | 0.020 |
Why?
| | Attitude of Health Personnel | 1 | 2010 | 49 | 0.020 |
Why?
| | Cholecystectomy | 1 | 1989 | 8 | 0.020 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2009 | 62 | 0.020 |
Why?
| | Respiratory Function Tests | 1 | 1989 | 16 | 0.020 |
Why?
| | Hospitalization | 1 | 2011 | 192 | 0.020 |
Why?
| | Body Mass Index | 1 | 2009 | 155 | 0.020 |
Why?
| | Hemangioma, Cavernous | 1 | 1988 | 1 | 0.020 |
Why?
| | Peritoneal Neoplasms | 1 | 1988 | 2 | 0.020 |
Why?
| | Colonic Neoplasms | 1 | 1988 | 7 | 0.020 |
Why?
| | Work Schedule Tolerance | 1 | 2008 | 5 | 0.020 |
Why?
| | Quality of Health Care | 1 | 2008 | 13 | 0.020 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2008 | 14 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2008 | 40 | 0.020 |
Why?
| | Aged | 2 | 2003 | 375 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2008 | 32 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2008 | 74 | 0.020 |
Why?
| | Hospital Costs | 1 | 2008 | 27 | 0.020 |
Why?
| | Esophageal Fistula | 1 | 2008 | 2 | 0.020 |
Why?
| | Thoracic Neoplasms | 1 | 2008 | 2 | 0.020 |
Why?
| | Respiratory Tract Fistula | 1 | 2008 | 2 | 0.020 |
Why?
| | Hemothorax | 1 | 2008 | 3 | 0.020 |
Why?
| | Cholangiography | 1 | 2008 | 2 | 0.020 |
Why?
| | Cystic Duct | 1 | 2008 | 2 | 0.020 |
Why?
| | Choledocholithiasis | 1 | 2008 | 2 | 0.020 |
Why?
| | Bronchial Fistula | 1 | 2008 | 3 | 0.020 |
Why?
| | Pneumonectomy | 1 | 2008 | 4 | 0.020 |
Why?
| | Empyema | 1 | 2008 | 3 | 0.020 |
Why?
| | Scoliosis | 1 | 2008 | 5 | 0.020 |
Why?
| | Gallstones | 1 | 2008 | 4 | 0.020 |
Why?
| | Pleural Effusion | 1 | 2008 | 5 | 0.020 |
Why?
| | Pancreatitis | 1 | 2008 | 8 | 0.020 |
Why?
| | Cholecystitis | 1 | 2008 | 6 | 0.020 |
Why?
| | Biliary Dyskinesia | 1 | 2008 | 8 | 0.020 |
Why?
| | Operating Rooms | 1 | 2007 | 4 | 0.020 |
Why?
| | Pharmacy Service, Hospital | 1 | 2007 | 8 | 0.020 |
Why?
| | Intestinal Volvulus | 1 | 2007 | 12 | 0.020 |
Why?
| | Blood Transfusion | 1 | 2007 | 13 | 0.020 |
Why?
| | Hemorrhage | 1 | 1987 | 18 | 0.020 |
Why?
| | Monitoring, Physiologic | 1 | 1987 | 24 | 0.020 |
Why?
| | Pancreas, Exocrine | 1 | 2005 | 1 | 0.020 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2005 | 1 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 2005 | 5 | 0.020 |
Why?
| | Venoms | 1 | 2005 | 2 | 0.020 |
Why?
| | Drug Synergism | 1 | 2005 | 7 | 0.020 |
Why?
| | Peptides | 1 | 2005 | 9 | 0.020 |
Why?
| | Wound Healing | 1 | 2005 | 7 | 0.020 |
Why?
| | Stem Cells | 1 | 2005 | 19 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2005 | 73 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2005 | 41 | 0.020 |
Why?
| | Urination Disorders | 1 | 2005 | 4 | 0.020 |
Why?
| | Urinary Tract Infections | 1 | 2005 | 17 | 0.020 |
Why?
| | Models, Animal | 1 | 2004 | 6 | 0.020 |
Why?
| | Neck | 1 | 2004 | 5 | 0.020 |
Why?
| | MutS Homolog 2 Protein | 1 | 2003 | 1 | 0.010 |
Why?
| | Organ Culture Techniques | 1 | 2003 | 3 | 0.010 |
Why?
| | Embryo, Mammalian | 1 | 2003 | 5 | 0.010 |
Why?
| | Genes, BRCA2 | 1 | 2003 | 5 | 0.010 |
Why?
| | Genes, BRCA1 | 1 | 2003 | 6 | 0.010 |
Why?
| | Proto-Oncogene Proteins | 1 | 2003 | 17 | 0.010 |
Why?
| | Neoplasm Proteins | 1 | 2003 | 29 | 0.010 |
Why?
| | Pedigree | 1 | 2003 | 53 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2003 | 32 | 0.010 |
Why?
| | Mesoderm | 1 | 2003 | 1 | 0.010 |
Why?
| | Fibroblast Growth Factor 7 | 1 | 2003 | 1 | 0.010 |
Why?
| | Oncogene Proteins | 1 | 2003 | 2 | 0.010 |
Why?
| | Connective Tissue | 1 | 2003 | 2 | 0.010 |
Why?
| | Muscle, Smooth | 1 | 2003 | 2 | 0.010 |
Why?
| | Phenotype | 1 | 2004 | 233 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2003 | 150 | 0.010 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2003 | 34 | 0.010 |
Why?
| | Respiratory Mucosa | 1 | 2002 | 4 | 0.010 |
Why?
| | Equipment Failure | 1 | 2002 | 9 | 0.010 |
Why?
| | Catheters, Indwelling | 1 | 2002 | 30 | 0.010 |
Why?
| | Lung Diseases | 1 | 2002 | 23 | 0.010 |
Why?
| | Registries | 1 | 2002 | 85 | 0.010 |
Why?
| | Kidney Diseases | 1 | 2002 | 69 | 0.010 |
Why?
| | Cardiovascular Diseases | 1 | 2002 | 49 | 0.010 |
Why?
| | Deoxyadenine Nucleotides | 1 | 1999 | 1 | 0.010 |
Why?
| | Deoxycytosine Nucleotides | 1 | 1999 | 1 | 0.010 |
Why?
| | Thymine Nucleotides | 1 | 1999 | 1 | 0.010 |
Why?
| | DNA-Activated Protein Kinase | 1 | 1999 | 1 | 0.010 |
Why?
| | Deoxyguanine Nucleotides | 1 | 1999 | 2 | 0.010 |
Why?
| | Catalysis | 1 | 1999 | 4 | 0.010 |
Why?
| | Oligonucleotides | 1 | 1999 | 4 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1999 | 9 | 0.010 |
Why?
| | Enzyme Activation | 1 | 1999 | 12 | 0.010 |
Why?
| | Mice, SCID | 1 | 1999 | 12 | 0.010 |
Why?
| | Substrate Specificity | 1 | 1999 | 16 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 1999 | 24 | 0.010 |
Why?
| | Cause of Death | 1 | 1999 | 11 | 0.010 |
Why?
| | Leg | 1 | 1998 | 4 | 0.010 |
Why?
| | Phlebography | 1 | 1998 | 6 | 0.010 |
Why?
| | Edema | 1 | 1998 | 8 | 0.010 |
Why?
| | Disease-Free Survival | 1 | 1998 | 45 | 0.010 |
Why?
| | Vascular Diseases | 1 | 1998 | 8 | 0.010 |
Why?
| | Ligation | 1 | 1998 | 3 | 0.010 |
Why?
| | Internal Fixators | 1 | 1997 | 3 | 0.010 |
Why?
| | Neck Injuries | 1 | 1996 | 1 | 0.010 |
Why?
| | Rib Fractures | 1 | 1996 | 2 | 0.010 |
Why?
| | Lung Injury | 1 | 1996 | 2 | 0.010 |
Why?
| | Glasgow Coma Scale | 1 | 1996 | 5 | 0.010 |
Why?
| | Multiple Trauma | 1 | 1996 | 12 | 0.010 |
Why?
| | Trauma Severity Indices | 1 | 1996 | 15 | 0.010 |
Why?
| | Accidental Falls | 1 | 1996 | 13 | 0.010 |
Why?
| | Contusions | 1 | 1996 | 8 | 0.010 |
Why?
| | Craniocerebral Trauma | 1 | 1996 | 18 | 0.010 |
Why?
| | Fractures, Bone | 1 | 1996 | 35 | 0.010 |
Why?
| | Life Tables | 1 | 1993 | 2 | 0.010 |
Why?
| | Methods | 1 | 1973 | 4 | 0.010 |
Why?
| | Aortography | 1 | 1973 | 2 | 0.010 |
Why?
| | Consciousness | 1 | 1991 | 1 | 0.010 |
Why?
| | Rats, Inbred Strains | 1 | 1991 | 1 | 0.010 |
Why?
| | Cerebrospinal Fluid Shunts | 1 | 1989 | 3 | 0.010 |
Why?
| | Adrenal Cortex Hormones | 1 | 1988 | 34 | 0.010 |
Why?
| | Venous Pressure | 1 | 1987 | 1 | 0.000 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|